Literature DB >> 21172867

CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition.

Daniel L Barber1, Katrin D Mayer-Barber, Carl G Feng, Arlene H Sharpe, Alan Sher.   

Abstract

Although CD4 T cells are required for host resistance to Mycobacterium tuberculosis, they may also contribute to pathology. In this study, we examine the role of the inhibitory receptor PD-1 and its ligand PD-L1 during M. tuberculosis infection. After aerosol exposure, PD-1 knockout (KO) mice develop high numbers of M. tuberculosis-specific CD4 T cells but display markedly increased susceptibility to infection. Importantly, we show that CD4 T cells themselves drive the increased bacterial loads and pathology seen in infected PD-1 KO mice, and PD-1 deficiency in CD4 T cells is sufficient to trigger early mortality. PD-L1 KO mice also display enhanced albeit less severe susceptibility, indicating that T cells are regulated by multiple PD ligands during M. tuberculosis infection. M. tuberculosis-specific CD8 T cell responses were normal in PD-1 KO mice, and CD8 T cells only had a minor contribution to the exacerbated disease in the M. tuberculosis-infected PD-1 KO and PD-L1 KO mice. Thus, in the absence of the PD-1 pathway, M. tuberculosis benefits from CD4 T cell responses, and host resistance requires inhibition by PD-1 to prevent T cell-driven exacerbation of the infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21172867      PMCID: PMC4059388          DOI: 10.4049/jimmunol.1003304

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  49 in total

1.  Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis.

Authors:  A M Caruso; N Serbina; E Klein; K Triebold; B R Bloom; J L Flynn
Journal:  J Immunol       Date:  1999-05-01       Impact factor: 5.422

Review 2.  What's good for the host is good for the bug.

Authors:  JoAnne L Flynn; John Chan
Journal:  Trends Microbiol       Date:  2005-03       Impact factor: 17.079

3.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency.

Authors:  F Altare; A Durandy; D Lammas; J F Emile; S Lamhamedi; F Le Deist; P Drysdale; E Jouanguy; R Döffinger; F Bernaudin; O Jeppsson; J A Gollob; E Meinl; A W Segal; A Fischer; D Kumararatne; J L Casanova
Journal:  Science       Date:  1998-05-29       Impact factor: 47.728

4.  Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production.

Authors:  Brandon M Sullivan; Ousman Jobe; Vanja Lazarevic; Kristine Vasquez; Roderick Bronson; Laurie H Glimcher; Igor Kramnik
Journal:  J Immunol       Date:  2005-10-01       Impact factor: 5.422

5.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 6.  Defects in the interferon-gamma and interleukin-12 pathways.

Authors:  Sergio D Rosenzweig; Steven M Holland
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

7.  Lethal tuberculosis in interleukin-6-deficient mutant mice.

Authors:  C H Ladel; C Blum; A Dreher; K Reifenberg; M Kopf; S H Kaufmann
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

8.  Characteristics of tuberculosis patients who generate secondary cases.

Authors:  T Rodrigo; J A Caylà; P García de Olalla; H Galdós-Tangüis; J M Jansà; P Miranda; T Brugal
Journal:  Int J Tuberc Lung Dis       Date:  1997-08       Impact factor: 2.373

9.  Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice.

Authors:  Yu-Jin Jung; Lynn Ryan; Ronald LaCourse; Robert J North
Journal:  J Exp Med       Date:  2005-06-13       Impact factor: 14.307

10.  Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis.

Authors:  A M Cooper; J Magram; J Ferrante; I M Orme
Journal:  J Exp Med       Date:  1997-07-07       Impact factor: 14.307

View more
  145 in total

Review 1.  Striking the right immunological balance prevents progression of tuberculosis.

Authors:  Shachi Pranjal Vyas; Ritobrata Goswami
Journal:  Inflamm Res       Date:  2017-07-15       Impact factor: 4.575

2.  STIM1 controls T cell-mediated immune regulation and inflammation in chronic infection.

Authors:  Ludovic Desvignes; Carl Weidinger; Patrick Shaw; Martin Vaeth; Theo Ribierre; Menghan Liu; Tawania Fergus; Lina Kozhaya; Lauren McVoy; Derya Unutmaz; Joel D Ernst; Stefan Feske
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

3.  Differentiation of antigen-specific T cells with limited functional capacity during Mycobacterium tuberculosis infection.

Authors:  Yun Hee Jeong; Bo-Young Jeon; Sun-Hwa Gu; Sang-Nae Cho; Sung Jae Shin; Jun Chang; Sang-Jun Ha
Journal:  Infect Immun       Date:  2013-10-14       Impact factor: 3.441

4.  Implications of Tuberculosis Reactivation after Immune Checkpoint Inhibition.

Authors:  Paul T Elkington; Adrian C Bateman; Gareth J Thomas; Christian H Ottensmeier
Journal:  Am J Respir Crit Care Med       Date:  2018-12-01       Impact factor: 21.405

Review 5.  Innate and Adaptive Cellular Immune Responses to Mycobacterium tuberculosis Infection.

Authors:  Katrin D Mayer-Barber; Daniel L Barber
Journal:  Cold Spring Harb Perspect Med       Date:  2015-07-17       Impact factor: 6.915

6.  Programmed death 1 lives up to its reputation in active tuberculosis.

Authors:  Suraj B Sable
Journal:  J Infect Dis       Date:  2013-05-09       Impact factor: 5.226

7.  Programmed death-1+ T cells inhibit effector T cells at the pathological site of miliary tuberculosis.

Authors:  A Singh; A Mohan; A B Dey; D K Mitra
Journal:  Clin Exp Immunol       Date:  2016-11-24       Impact factor: 4.330

8.  Programmed cell death 1 inhibits inflammatory helper T-cell development through controlling the innate immune response.

Authors:  Yuxiang Rui; Tasuku Honjo; Shunsuke Chikuma
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

Review 9.  Fighting Persistence: How Chronic Infections with Mycobacterium tuberculosis Evade T Cell-Mediated Clearance and New Strategies To Defeat Them.

Authors:  Laurisa Ankley; Sean Thomas; Andrew J Olive
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 10.  Costimulatory and Coinhibitory Receptor Pathways in Infectious Disease.

Authors:  John Attanasio; E John Wherry
Journal:  Immunity       Date:  2016-05-17       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.